Stay updated on Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.

Latest updates to the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page
- Check2 days agoChange DetectedNo text changes are listed for the page. The current content is unchanged according to the input data.SummaryDifference0.1%

- Check9 days agoChange DetectedRecruitment status was updated to indicate that no new participants are being enrolled, clarifying the study's current accessibility. Navigation and labeling changes were made, including adding links such as How to Read a Study Record, Common Questions, How to Join a Study, and standardizing the Intervention/Treatment label, along with a revision version change from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check17 days agoChange DetectedThe page's revision tag was updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a minor, non-user-facing update to the site.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page revision was updated to v3.5.4, replacing the previous v3.5.3. This indicates a new version of the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check45 days agoChange DetectedNo additions or deletions are listed in the changes source for this page; therefore, no specific edits are captured. If updates were present, they would appear as textual changes to study details, eligibility, or locations.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page’s footer version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects a site release/update rather than any change to the clinical trial study content.SummaryDifference0.1%

Stay in the know with updates to Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in Rare Genetic Obesity: Phase 2 Clinical Trial page.